1. Home
  2. ADAG vs DSX Comparison

ADAG vs DSX Comparison

Compare ADAG & DSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.64

Market Cap

254.4M

Sector

Health Care

ML Signal

HOLD

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$2.39

Market Cap

291.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
DSX
Founded
2011
1999
Country
China
Greece
Employees
N/A
939
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
254.4M
291.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ADAG
DSX
Price
$3.64
$2.39
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$8.25
N/A
AVG Volume (30 Days)
186.8K
1.1M
Earning Date
04-01-2026
05-28-2026
Dividend Yield
N/A
1.62%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.28
Revenue Next Year
N/A
$4.87
P/E Ratio
N/A
$16.02
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$1.46
52 Week High
$4.75
$2.92

Technical Indicators

Market Signals
Indicator
ADAG
DSX
Relative Strength Index (RSI) 50.78 44.62
Support Level $3.29 $2.29
Resistance Level $4.09 $2.63
Average True Range (ATR) 0.31 0.13
MACD 0.00 -0.01
Stochastic Oscillator 39.47 20.49

Price Performance

Historical Comparison
ADAG
DSX

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

Share on Social Networks: